Induction of ferroptosis in head and neck cancer: A novel bridgehead for fighting cancer resilience

被引:14
作者
Lee, Jaewang [1 ]
Roh, Jong-Lyel [1 ,2 ]
机构
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea
[2] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Gyeonggi do, Seongnam 13496, South Korea
基金
新加坡国家研究基金会;
关键词
Head and neck cancer; Ferroptosis; Treatment; Iron; Lipid peroxidation; CISPLATIN-RESISTANT HEAD; CELL-DEATH; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; DOWN-REGULATION; INHIBITION; IRON; THERAPY; NRF2; APOPTOSIS;
D O I
10.1016/j.canlet.2022.215854
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Most head and neck cancers (HNCs) originate from mucosal epithelial cells and show epithelial traits. It often changes to a mesenchymal or poorly differentiated state as cancer progresses, leading to invasion, metastasis, and resistance to treatment. The loss of epithelial traits by the epithelial-mesenchymal transition may render resilient cancers vulnerable to a novel non-apoptotic regulated cell death ferroptosis by the iron-dependent accumulation of excessive lipid peroxidation. By regulating mitochondrial or iron metabolism, intracellular ferrous iron and lipid peroxidation accumulation can be boosted, making resistant cancer cells more susceptible to ferroptosis. This article discusses the potential effect of ferroptosis induction as a novel treatment for resilient HNCs.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Novel developments in diagnostics and therapy of head and neck cancer
    Uhl B.
    Baumeister P.
    Reichel C.
    MMW - Fortschritte der Medizin, 2021, 163 (21-22) : 60 - 65
  • [32] MERTK as a novel therapeutic target in head and neck cancer
    von Maessenhausen, Anne
    Sanders, Christine
    Thewes, Britta
    Deng, Mario
    Queisser, Angela
    Vogel, Wenzel
    Kristiansen, Glen
    Duensing, Stefan
    Schroeck, Andreas
    Bootz, Friedrich
    Brossart, Peter
    Kirfel, Jutta
    Heasley, Lynn
    Braegelmann, Johannes
    Perner, Sven
    ONCOTARGET, 2016, 7 (22) : 32678 - 32694
  • [33] Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer
    Ito, Emma
    Yip, Kenneth W.
    Liu, Fei-Fei
    FUTURE ONCOLOGY, 2011, 7 (05) : 595 - 597
  • [34] Head and neck cancer
    McMahon, S
    Chen, AY
    CANCER AND METASTASIS REVIEWS, 2003, 22 (01) : 21 - 24
  • [35] Head and neck cancer
    Steve McMahon
    Amy Y. Chen
    Cancer and Metastasis Reviews, 2003, 22 : 21 - 24
  • [36] Alterperylenol as a Novel Thioredoxin Reductase Inhibitor Induces Liver Cancer Cell Apoptosis and Ferroptosis
    Xi, Junmin
    Tian, Li-Li
    Xi, Jiahui
    Girimpuhwe, Desire
    Huang, Chongfei
    Ma, Ruixia
    Yao, Xiaojun
    Shi, Danfeng
    Bai, Zhongtian
    Wu, Quan-Xiang
    Fang, Jianguo
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2022, 70 (50) : 15763 - 15775
  • [37] Ferroptosis-Related Genes Are Associated with Radioresistance and Immune Suppression in Head and Neck Cancer
    Huang, Ping
    Ning, Xuejian
    Kang, Min
    Wang, Rensheng
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (03) : 100 - 113
  • [38] Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
    Su, Yanwei
    Zhao, Bin
    Zhou, Liangfu
    Zhang, Zheyuan
    Shen, Ying
    Lv, Huanhuan
    AlQudsy, Luban Hamdy Hameed
    Shang, Peng
    CANCER LETTERS, 2020, 483 : 127 - 136
  • [39] Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway
    Yang, Yang
    Zhang, Zi-Jian
    Wen, Yu
    Xiong, Li
    Huang, Yun-Peng
    Wang, Yong-Xiang
    Liu, Kai
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (11) : 1668 - 1679
  • [40] Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
    Zhang, Chen
    Liu, Xinyin
    Jin, Shidai
    Chen, Yi
    Guo, Renhua
    MOLECULAR CANCER, 2022, 21 (01)